The clinical efficacy of endometriosis diagnosis using I-123 MIBG SPECT and MRI image fusion

The clinical efficacy of endometriosis diagnosis using I-123 MIBG SPECT and MRI image fusion - The clinical efficacy of endometriosis diagnosis using I-123 MIBG SPECT and MRI image fusion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030676

Enrollment

Registered

2018-01-04

Start date

2018-01-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Iodine I 123 metaiodobenzylguanidine 111 MBq i.v. Administration period:One day,1 time

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patient who gives written informed consent before enrolling the study.

Exclusion criteria

Exclusion criteria: Patient who is considered ineligible for enrolling the study by a principal investigator or sub-investigator.

Design outcomes

Primary

Measure	Time frame
To compare the operation results and I-123 MIBG SPECT/MRI fusion image results of the endometriosis and to calculate sensitivity and specificity.	—

Countries

Japan

Contacts

Public ContactNaoki Kan

Kansai Medical University Medical Center Department of Radiology

r0149404@gmail.com06-6992-1001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026